Skip to main content

Ingenuity Systems Joins Biomarkers Consortium

NEW YORK (GenomeWeb News) — Ingenuity Systems said yesterday that it has joined the Biomarkers Consortium, a public-private endeavor aimed at developing, discovering, and qualifying new biomarkers for drug development, preventive medicine, and medical diagnostics.
 
The consortium was founded by the Foundation for the National Institutes of Health, the National Institutes of Health, the US Food and Drug Administration, the Centers for Medicare and Medicaid Services, and the Pharmaceutical Research and Manufacturers of America. It now comprises around 30 partners, including companies, patient advocacy organizations, government groups, and non-profits.
 
The consortium this summer launched a website that offers more information, accepts proposals for projects, and offers information on funding opportunities.
  
Ingenuity makes pathway analysis and knowledge-base software that helps researchers explore, analyze, and interpret scientific literature and data.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.